High Net Worth Advisory Group LLC Spring Works Therapeutics, Inc. Transaction History

High Net Worth Advisory Group LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 24, 2022	BUY	$24.1 - $39.66 $12,050 - $19,830	500 Added 100.0%	1,000 $29,000
Q2 2022 Aug 10, 2022	SELL	$18.36 - $60.07 $9,180 - $30,035	-500 Reduced 50.0%	500 $12,000
Q4 2021 Apr 27, 2022	BUY	$53.3 - $75.84 $53,300 - $75,840	1,000 New	1,000 $56,000

238

69.8M

144K

257K

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.43B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

Get notified when there are updates to the investment portfolio of High Net Worth Advisory Group LLC, based on Form 13F filings with the SEC.

Stay updated on High Net Worth Advisory Group LLC with notifications on news.